Search Results | Showing 41 - 50 of 72 results for "GMO" |
| | ... portfolio is made up of four other managers including value managers, Bernstein and LSV and growth managers, Alliance Growth and GMO. |
| | | The $14 billion REST Superannuation has axed an Australian Equities mandate with GMO due to concerns with the fund manager's team changes. According to Damian Hill, chief executive of REST Superannuation, the super fund ended a four year relationship ... |
| | | Global investment management giant GMO has added three senior investment professionals to its Sydney-based Australian Equities team. Geoff Wells, Mark Thompson and Bradley Grehan will bring a combined 40 years of experience to the GMO Australian Equities ... |
| | | Former GMO strategist Jack Gray has joined alternative investment specialist, Brookvine, in a special advisory role. In January, Gray resigned from GMO as head of strategy to pursue academic projects and work with the United Nations High Commissioner ... |
| | | The former head of strategy at Grantham Mayo van Otterloo (GMO), Jack Gray, recently announced his resignation from the company. According to Gray, the resignation stems from his desire to "look around and try to do something different." "I'm looking ... |
| | | Former GMO quantitative managers Max Cappetta and Anthony Corr have resurfaced and teamed up with former MIR quant director Brett McElwee to form their own boutique - Continuum Capital Management. The new boutique will come under the wing of boutique ... |
| | | ... also added a customised value strategy alpha mandate, run by Barclays Global Investors. Mandates with Bernstein, Concord and GMO have been terminated. |
| | | GMO's Australian small cap shares funds have been downgraded by Morningstar after the departure of former head of equities Max Cappetta and head of equity research Anthony Corr. "They're a big loss to the firm, and while GMO has sizeable resources ... |
| | | ... emerging markets and small caps, as well as all their international managers, including Alliance, Barclays, Credit Suisse and GMO. "It's a truism that markets are always changing. But we see regular reviews of our investments in all markets and asset ... |
| | | ... of private equity firms in business today worldwide will cease to exist within five years, according to predictions made by GMO chairman, Jeremy Grantham. In his quarterly letter, Grantham said the spectre of raised corporate taxes, a change in legislation ... |
|